These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9101299)

  • 21. [Characterization of steroid 21-hydroxylase gene mutations in a oligosymptomatic form of congenital adrenal hyperplasia: family study].
    Martínez Olmos MA; Varela JM; Ezquieta B; Hillman N; Díez JJ
    Med Clin (Barc); 1997 Oct; 109(11):421-4. PubMed ID: 9379733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restriction fragment length polymorphism study of families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Taiwan.
    Lee JS; Tsai HM; Shieh RP; Chen SH; Tsai WY; Chung BC
    J Formos Med Assoc; 1990 Jul; 89(7):534-40. PubMed ID: 1979594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct analysis of CYP21B genes in 21-hydroxylase deficiency using polymerase chain reaction amplification.
    Owerbach D; Crawford YM; Draznin MB
    Mol Endocrinol; 1990 Jan; 4(1):125-31. PubMed ID: 2325662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic analysis of the steroid 21-hydroxylase gene following in vitro amplification of genomic DNA.
    Rumsby G; Skinner C; Honour JW
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):827-9. PubMed ID: 1562557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splicing mutation in CYP21 associated with delayed presentation of salt-wasting congenital adrenal hyperplasia.
    Kohn B; Day D; Alemzadeh R; Enerio D; Patel SV; Pelczar JV; Speiser PW
    Am J Med Genet; 1995 Jul; 57(3):450-4. PubMed ID: 7677150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of polymorphic 21-hydroxylase gene (CA21HB) mutations in salt-losing congenital adrenal hyperplasia.
    Jospe N; Donohoue PA; Van Dop C; McLean RH; Bias WB; Migeon CJ
    Biochem Biophys Res Commun; 1987 Feb; 142(3):798-804. PubMed ID: 3030300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid identification of deoxyribonucleic acid sequence differences in cytochrome P-450 21-hydroxylase (CYP21) genes with denaturing gradient gel blots.
    Reindollar RH; Su BC; Bayer SR; Gray MR
    Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):184-91. PubMed ID: 1346350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tracing past population migrations: genealogy of steroid 21-hydroxylase (CYP21) gene mutations in Finland.
    Levo A; Jääskeläinen J; Sistonen P; Sirén MK; Voutilainen R; Partanen J
    Eur J Hum Genet; 1999; 7(2):188-96. PubMed ID: 10196702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amplification refractory mutation system analysis of point mutations by capillary electrophoresis.
    Carrera P; Righetti PG; Gelfi C; Ferrari M
    Methods Mol Biol; 2001; 163():95-108. PubMed ID: 11242967
    [No Abstract]   [Full Text] [Related]  

  • 30. Novel nonsense mutation (W22X) in CYP21A2 gene causing salt-wasting congenital adrenal hyperplasia in a compound heterozygous girl.
    Di Pasquale L; Indovina S; Wasniewska M; Mirabelli S; Porcelli P; Rulli I; Salzano G; De Luca F
    J Endocrinol Invest; 2007 Oct; 30(9):806-7. PubMed ID: 17993777
    [No Abstract]   [Full Text] [Related]  

  • 31. Functional analysis of four CYP21 mutations from spanish patients with congenital adrenal hyperplasia.
    Nunez BS; Lobato MN; White PC; Meseguer A
    Biochem Biophys Res Commun; 1999 Sep; 262(3):635-7. PubMed ID: 10471376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Technique of PCR-ACRS for the detection of CYP21 gene mutations].
    Liao XY; Zhang YF; Gu XF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):449-51. PubMed ID: 14556206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in steroid 21-hydroxylase (CYP21).
    White PC; Tusie-Luna MT; New MI; Speiser PW
    Hum Mutat; 1994; 3(4):373-8. PubMed ID: 8081391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mutation in the promoter region of 21-hydroxylase gene of patients with congenital adrenal hyperplasia].
    Zhao Y; Ye J; Yang X; Gu X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Jun; 16(3):156-9. PubMed ID: 10359865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CYP21A2 gene mutation in South Indian children with congenital adrenal hyperplasia.
    Ganesh R; Suresh N; Janakiraman L; Ravikumar K
    Indian Pediatr; 2015 Aug; 52(8):710-1. PubMed ID: 26388637
    [No Abstract]   [Full Text] [Related]  

  • 36. A steroid 21-hydroxylase allele concomitantly carrying four disease-causing mutations is not uncommon in the swedish population.
    Wedell A; Chun X; Luthman H
    Hum Genet; 1994 Feb; 93(2):204-6. PubMed ID: 8112748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene.
    Rhéaume E; Simard J; Morel Y; Mebarki F; Zachmann M; Forest MG; New MI; Labrie F
    Nat Genet; 1992 Jul; 1(4):239-45. PubMed ID: 1363812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exon 7 Ncol restriction site within CYP21B (steroid 21-hydroxylase) is a normal polymorphism.
    Donohoue PA; Sandrini Neto R; Collins MM; Migeon CJ
    Mol Endocrinol; 1990 Sep; 4(9):1354-62. PubMed ID: 1978247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital adrenal hyperplasia. Molecular characterization.
    Ko TM; Kao CH; Ho HN; Tseng LH; Hwa HL; Hsu PM; Chuang SM; Lee TY
    J Reprod Med; 1998 Apr; 43(4):379-86. PubMed ID: 9583072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular analysis of CYP21 gene mutations carried on HLA-B14 positive haplotypes.
    Dondi E; Cuccia M; Keller E; Martinetti M; Larizza D; Albert ED
    Eur J Immunogenet; 1994 Oct; 21(5):341-50. PubMed ID: 9098443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.